Thinking about the future, it’s inevitable that other cancer drugs like Rasonque will launch at similar or even higher prices. In the long run, how sustainable is this?

Since USPSTF recommendations guide insurer decisions on what types of preventive care to fully cover, the panel's ongoing upheaval may lead to coverage limits.

The Trump administration has mostly shut down the Agency for Healthcare Research and Quality, which has been key in raising awareness and improving patient safety.

Bank of America is bucking the downward trend in employer-sponsored coverage of GLP-1s for weight loss by maintaining its comparatively generous policies.

President Trump vowed better access to GLP-1 weight loss drugs for Medicaid recipients. But thus far only Indiana has publicly signed on with the administration’s demo.

Trump signed an executive order to reshape the childhood vaccine schedule. He made multiple false claims, including repeating the debunked vaccines and autism link.

Proposed bills could directly lead to lowering patient out-of-pocket costs for items like insulin. Others may indirectly impact costs by curbing possible patent abuses,

The abortion pill mifepristone remains embroiled in U.S. legal, political and regulatory battles, despite the Supreme Court temporarily restoring mail access.

The debate between Medicare for All and Medicare by Choice advocates, both of whom seek better affordability, is shaping up to be an interesting one in the coming years.

The U.S. mortality rate reached a record low in 2025. But it lags behind peers due to persistent issues like chronic disease, gun violence and unequal healthcare access.

As more people go without insurance, hospital revenues decline, insurance premiums throughout the system increase and medical debt levels rise.

Though FDA would normally follow a panel’s advice to move ahead with compounded peptides, it’s unclear how it will act, because FDA staff are opposed to easing access.

By ending subsidies to standalone prescription drug plans, it’s expected they will have to raise premiums for at least 11 million Medicare beneficiaries.

Obamacare faces renewed "death spiral" concerns as premiums are projected to jump 14% in 2027, following last year's 20% increase.

It’s possible that the decadeslong trend of rising temperatures globally is leading to the more frequent presence of diseases more typically found in tropical regions.

though MAHA’s food agenda still features prominently, in practice achieving its goals is being made increasingly difficult by a number of Trump administration policies.

Millions of Americans are currently injecting unapproved chemicals like peptides promoted by hodgepodge of wellness influencers and celebrity podcasters.

The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance against metastatic pancreatic cancer.

By mandating hydration breaks at this year's World Cup, FIFA is facilitating a change with huge financial implications as airing more ads boosts broadcasting revenue.

While the most favored nation initiatives have bold aims to lower the cost of drugs, the impact is limited, and in some instances unclear, a case of style over substance.

Should Medicare change the default option for new beneficiaries to Medicare Advantage or an ACO, this could backfire as costs could rise and access restrictions increase.

In Congress, hearings on healthcare tend to function as venues for adversarial political messaging and electoral gain rather than legislative consensus-building.

White House model estimates on cost savings from most-favored nation drug prices are speculative and depend on a set of unrealistic assumptions.

Those with a vested interest in the status quo, are resisting transparency regulations. After all, maintaining opaque pricing in healthcare has been profitable to them.

Despite more than two decades of safe and effective use, the abortion pill is once more in the crosshairs of American politics and the judicial system.

Policy experts suggest reform of prior authorization that would require coverage decisions be supported solely by evidence being reviewed by independent clinicians.

DTC portals for drugs are a solution to a problem that wouldn’t exist if insurer coverage were better. The most acute issue for patients is lack of comprehensive coverage

If increased transparency isn’t the answer, what could meaningfully lower patients’ out-of-pocket costs? Reduced prices of care throughout all of healthcare would help.

With a new yearly cap on drug costs, Medicare patients are experiencing lower bills and fewer disruptions.

Examples of behavioral changes suggest the power of messaging when disseminated from a bully pulpit. Kennedy’s conspicuous visibility reinforces his reach.

Trump’s orders move the U.S. a few steps closer to more widespread research on and use of two sets of controversial yet promising drugs, psychedelic and cannabis products

Trump administration is considering auto-enrollment for Medicare enrollees in Medicare Advantage. This suggests a preference for the program over traditional Medicare.

Healthcare initiatives being proposed like Patients' Bill of Rights offer a roadmap for Democrats’ priorities, with midterms looming and a presidential election in 2028.

On top of the current financial burdens for those trying to pay healthcare bills, medical debt can lead to undertreatment in future across a spectrum of health needs.

Despite a flurry of executive actions and rhetoric about their supposed impact, thus far most favored nation policies have had little effect on prices that consumers pay.

Repealing the HMO Act is not on any politician’s agenda. But perhaps a better regulated, less heavily profit-oriented system of multiple payers could work in the U.S.

Medicare by Choice would make available Medicare-like health plans to everyone who wants such coverage. These would then compete against private plans.

Amid declining test scores, the country has pivoted away from screens and invested in back-to-basics school materials.

Rising hospital costs translate to increasing premiums, as insurers pass on increased spending. Patients may be impacted by this as much, if not more, than drug costs.

In its quiescence to the West’s war on Iran, India is squandering a precious legacy.

The main criticism of high-deductible health plans has been that people with such coverage typically must pay thousands of dollars out-of-pocket when they do get sick.

It’s unknown at this time whether additional forced disenrollment of beneficiaries will occur later this year. But it seems likely that more plans will exit the market.

On top of continued elevated inflation, it’s what the Consumer Price Index doesn’t measure — certain patient healthcare costs — that's enhancing the affordability crisis.

For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could outweigh potential benefits.

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

Jackson’s vocal advocacy caused a shift in both behavior and attitudes toward HIV/AIDS. He helped chart a course of action that led to improved prevention and treatments.

The Trump administration says it wants to tackle the "addiction epidemic." But it's eliminating addiction treatment resources and access to mental healthcare.

Critics warn that health savings accounts aren’t the fix some suggest they may be. The financial risks for patients are particularly large should they become ill.